T. Rowe Price Associates’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-26,238
Closed -$4.18M 2938
2021
Q1
$4.18M Sell
26,238
-15,210
-37% -$2.58M ﹤0.01% 1505
2020
Q4
$6.34M Buy
+41,448
New +$7.44M ﹤0.01% 1415
2018
Q3
Sell
-2,040
Closed -$5.59M 2594
2018
Q2
$5.59M Buy
2,040
+637
+45% +$1.47M ﹤0.01% 1423
2018
Q1
$3.81M Buy
+1,403
New +$3.22M ﹤0.01% 1461
2017
Q4
Sell
-44
Closed -$89K 2589
2017
Q3
$89K Hold
44
﹤0.01% 2504
2017
Q2
$51K Hold
44
﹤0.01% 2527
2017
Q1
$71K Hold
44
﹤0.01% 2517
2016
Q4
$77K Hold
44
﹤0.01% 2494
2016
Q3
$109K Sell
44
-1
-2% -$2.47K ﹤0.01% 2433
2016
Q2
$111K Hold
45
﹤0.01% 2411
2016
Q1
$161K Buy
45
+1
+2% +$3.47K ﹤0.01% 2334
2015
Q4
$204K Buy
+44
New +$144K ﹤0.01% 2297
2015
Q3
Sell
-3,200
Closed -$27M 2526
2015
Q2
$27M Buy
3,200
+2,124
+197% +$20.3M 0.01% 1055
2015
Q1
$10.8M Buy
+1,076
New +$9.89M ﹤0.01% 1320

Other funds holding IMUX